Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127565281 | 12756528 | 1 | I | 20160906 | 20160917 | 20160917 | PER | US-ASTRAZENECA-2016SE95759 | ASTRAZENECA | 59.00 | YR | M | Y | 0.00000 | 20160917 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127565281 | 12756528 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 19810 | ||||||||||
| 127565281 | 12756528 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 1509507A | 0 | 10 | MG | QD | |||||||
| 127565281 | 12756528 | 3 | C | ADEMPAS | RIOCIGUAT | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127565281 | 12756528 | Decreased appetite | |
| 127565281 | 12756528 | Dyspepsia | |
| 127565281 | 12756528 | Nausea | |
| 127565281 | 12756528 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127565281 | 12756528 | 2 | 201606 | 0 |